InvestorsHub Logo
Followers 30
Posts 2489
Boards Moderated 1
Alias Born 05/03/2012

Re: rafunrafun post# 300732

Tuesday, 09/22/2020 5:57:52 PM

Tuesday, September 22, 2020 5:57:52 PM

Post# of 428806
He is bad, how do you go all these years without any kind of expansion in the ROW. He hung his hat on Canada, China, a few middle eastern countries and hopes for just the EU. He forgot about half the world. They have not provided us with an image for Vascepa, when you think Vascepa what do you think of??? Ads are dull and I can't forget after marketing marine for over a year they suddenly mention on a conference call they would shift to Cardiologists.....who they should have targeted first....ugh. These guys are great for getting a drug from concept through clinical trial and should have sold after reduce-it results. They have no concept of partnering, leveraging partnerships and building relationships....the FDA still screws with them.

Sorry, I am venting as we are all watching our hard earn money swirl in a toilet. I owe my quality of life to this drug but this company can't seem to make anyone understand. The only people who get it are shareholders who are mostly patients.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News